Vital Signs - Ocular Drug Delivery: Expanding the Field of Vision
Vital Signs - Ocular Drug Delivery: Expanding the Field of Vision
RELEASE DATE
30-Mar-2009
30-Mar-2009
REGION
North America
North America
Research Code: 9561-00-87-00-00
SKU: HC00565-NA-MR_04037
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00565-NA-MR_04037
Description
This issue of Vital Signs, released on March 30, 2009, provides a strategic overview of selected new technology approaches and opportunities in ocular drug delivery and ophthalmic pharmaceuticals. Additionally, a company spotlight is provided for Inotek Pharmaceuticals, a company developing focused on developing products from its research into the regulation of cellular responses to tissue damaging conditions such as hypoxia, ischemia-reperfusion, diabetes, glaucoma, and angiogenic dysregulation. Reimbursement and regulatory news from the FDA is also provided for the week of March 16, 2009.
Table of Contents
This week's issue:
Related Research
Popular Topics
This issue of Vital Signs, released on March 30, 2009, provides a strategic overview of selected new technology approaches and opportunities in ocular drug delivery and ophthalmic pharmaceuticals. Additionally, a company spotlight is provided for Inotek Pharmaceuticals, a company developing focused on developing products from its research into the regulation of cellular responses to tissue damaging conditions such as hypoxia, ischemia-reperfusion, diabetes, glaucoma, and angiogenic dysregulation. Reimbursement and regulatory news from the FDA is also provided for the week of March 16, 2009.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-87-00-00 |
Is Prebook | No |